Previous Close | 0.0007 |
Open | 0.0002 |
Bid | 0.0200 x 4000 |
Ask | 0.0300 x 1100 |
Day's Range | 0.0007 - 0.0007 |
52 Week Range | 0.0007 - 0.1150 |
Volume | |
Avg. Volume | 54,540 |
Market Cap | N/A |
Beta (5Y Monthly) | -0.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ALTUW
ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (Nasdaq: ALTUU, ALTU, ALTUW) (the “Company”), today announced that it will redeem all of its outstanding shares of Class A common stock initially issued as part of the units sold in its initial public offering (the “Public Shares”), effective as of March 12, 2024, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. Th
ATLANTA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (Nasdaq: ALTUU, ALTU, ALTUW) (“Altitude”), announced today that its board of directors (the “Board”) has extended the date by which Altitude must consummate an initial business combination (the “Deadline Date”) for an additional month, from February 11, 2024 to March 11, 2024. Altitude’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), gives the Board the right to extend the Deadline Date, without
ATLANTA and PALO ALTO, Calif. and TUCSON, Ariz., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (“Altitude”) (Nasdaq: ALTU) and Picard Medical, Inc. (“Picard”), the parent company of SynCardia Systems, LLC (“SynCardia”), the global leader in mechanical heart replacement technology, today announced the filing of a preliminary proxy statement on Schedule 14A with the U.S. Securities and Exchange Commission (“SEC”), and in connection with their previously announced business combinatio